Fizazi K - Search Results

1

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.

Fizazi K, Pagliaro L, Laplanche A, Fléchon A, Mardiak J, Geoffrois L, Kerbrat P, Chevreau C, Delva R, Rolland F, Theodore C, Roubaud G, Gravis G, Eymard JC, Malhaire JP, Linassier C, Habibian M, Martin AL, Journeau F, Reckova M, Logothetis C, Culine S. Fizazi K, et al. Lancet Oncol. 2014 Dec;15(13):1442-1450. doi: 10.1016/S1470-2045(14)70490-5. Epub 2014 Nov 13. Lancet Oncol. 2014. PMID: 25456363 Free PMC article. Clinical Trial.

2

Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours.

Fizazi K, Farhat F, Theodore C, Rixe O, Le Cesne A, Comoy E, Le Chevalier T. Fizazi K, et al. Br J Cancer. 1997;75(1):76-8. doi: 10.1038/bjc.1997.12. Br J Cancer. 1997. PMID: 9000601 Free PMC article.

3

[Primary mediastinal non-seminomatous germ-cell tumors: from clinics to biology].

Fizazi K, Culine S, Droz JP, Le Chevalier T, Ruffié P, Théodore C. Fizazi K, et al. Bull Cancer. 1997 Mar;84(3):313-27. Bull Cancer. 1997. PMID: 9207879 Review. French.

4

Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy.

Soria JC, Fizazi K, Piron D, Kramar A, Gerbaulet A, Haie-Meder C, Perrin JL, Court B, Wibault P, Théodore C. Soria JC, et al. Among authors: fizazi k. Ann Oncol. 1997 Nov;8(11):1089-98. doi: 10.1023/a:1008248319036. Ann Oncol. 1997. PMID: 9426328 Free article.

5

Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy.

Fizazi K, Culine S, Droz JP, Kramar A, Théodore C, Ruffié P, Le Chevalier T. Fizazi K, et al. J Clin Oncol. 1998 Feb;16(2):725-32. doi: 10.1200/JCO.1998.16.2.725. J Clin Oncol. 1998. PMID: 9469363

6

Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?

Fizazi K, Culine S, Droz JP, Terrier-Lacombe MJ, Théodore C, Wibault P, Rixe O, Ruffié P, Le Chevalier T. Fizazi K, et al. Eur J Cancer. 1998 Feb;34(3):347-52. doi: 10.1016/s0959-8049(97)10021-1. Eur J Cancer. 1998. PMID: 9640220 Review.

7

[Metastatic carcinoma of unknown origin].

Fizazi K, Culine S. Fizazi K, et al. Bull Cancer. 1998 Jul;85(7):609-17. Bull Cancer. 1998. PMID: 9752267 Free article. Review. French.

8

Evaluation of estramustine phosphate combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Culine S, Kattan J, Zanetta S, Théodore C, Fizazi K, Droz JP. Culine S, et al. Among authors: fizazi k. Am J Clin Oncol. 1998 Oct;21(5):470-4. doi: 10.1097/00000421-199810000-00010. Am J Clin Oncol. 1998. PMID: 9781602 Clinical Trial.

9

Is òne cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms.

Fizazi K, Zelek L. Fizazi K, et al. Ann Oncol. 2000 Feb;11(2):133-49. doi: 10.1023/a:1008344014518. Ann Oncol. 2000. PMID: 10761747 Free article. Review.

10

Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer.

Fizazi K, Ducreux M, Ruffié P, Bonnay M, Daniel C, Soria JC, Hill C, Fandi A, Poterre M, Smith M, Armand JP. Fizazi K, et al. J Clin Oncol. 2000 Jun;18(11):2293-300. doi: 10.1200/JCO.2000.18.11.2293. J Clin Oncol. 2000. PMID: 10829050 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters